News

CEFI, as a member of the Interministerial Commission to act against activities which infringe intellectual and industrial property rights, backs the institutional anti-counterfeiting campaign carried out by the Ministry of Industry, Trade and Tourism together with the Spanish Patent and […]

BIOSIMILAR AND GENERIC DRUGS With the document of statements, the CEFI Foundation analyses each of the specific measures proposed in the Plan in detail but, in general, it believes that in the draft of the plan, the basic principles of […]

The reference price system and annual reference price orders are intended to contribute to the sustainability of the SNS. They should also promote the right balance between innovative generic/biosimilar, competition and competitiveness in the pharmaceutical and health market. Price decisions […]

Farmaindustria has published an interesting decalogue on the value of brands. It is important to strengthen the role of brands as industrial property and business assets that strengthen competitiveness in the market and inform us about their attributes. They highlight […]